92 related articles for article (PubMed ID: 21508411)
1. CDK6 kinase activity is required for thymocyte development.
Hu MG; Deshpande A; Schlichting N; Hinds EA; Mao C; Dose M; Hu GF; Van Etten RA; Gounari F; Hinds PW
Blood; 2011 Jun; 117(23):6120-31. PubMed ID: 21508411
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration.
Diril MK; Ratnacaram CK; Padmakumar VC; Du T; Wasser M; Coppola V; Tessarollo L; Kaldis P
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3826-31. PubMed ID: 22355113
[TBL] [Abstract][Full Text] [Related]
3. CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver.
Hu AJ; Li W; Dinh C; Zhang Y; Hu JK; Daniele SG; Hou X; Yang Z; Asara JM; Hu GF; Farmer SR; Hu MG
Nat Commun; 2024 Feb; 15(1):1091. PubMed ID: 38316780
[TBL] [Abstract][Full Text] [Related]
4. Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancer.
Moukas SI; Kasimir-Bauer S; Tewes M; Kolberg HC; Hoffmann O; Kimmig R; Keup C
Sci Rep; 2023 Dec; 13(1):21262. PubMed ID: 38040730
[TBL] [Abstract][Full Text] [Related]
5. CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation.
Hu AJ; Li W; Pathak A; Hu GF; Hou X; Farmer SR; Hu MG
Front Mol Biosci; 2023; 10():1146047. PubMed ID: 37664186
[No Abstract] [Full Text] [Related]
6. A novel immune-related gene signature correlated with serum IL33 expression in acute myeloid leukemia prognosis.
Xie JY; Wang WJ; Wang N; Dong Q; Han H; Feng YP; Yuan Y; Feng J; Chen K
Am J Transl Res; 2023; 15(6):4332-4344. PubMed ID: 37434810
[TBL] [Abstract][Full Text] [Related]
7. On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.
Kim CG; Kim MH; Kim JH; Kim SG; Kim GM; Kim TY; Ryu WJ; Kim JY; Park HS; Park S; Cho YU; Park BW; Kim SI; Jeong J; Sohn J
Breast Cancer Res; 2023 Jan; 25(1):4. PubMed ID: 36635767
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 6 (CDK6) as a potent regulator of the ovarian primordial-to-primary follicle transition.
Ataei-Nazari S; Amoushahi M; Madsen JF; Jensen J; Heuck A; Mohammadi-Sangcheshmeh A; Lykke-Hartmann K
Front Cell Dev Biol; 2022; 10():1036917. PubMed ID: 36619863
[No Abstract] [Full Text] [Related]
9. Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma.
Li J; Li P; Su H; Feng H; Bai Z; Xi Y
Int J Gen Med; 2022; 15():7265-7276. PubMed ID: 36133914
[TBL] [Abstract][Full Text] [Related]
10. A kinase-independent function of cyclin-dependent kinase 6 promotes outer radial glia expansion and neocortical folding.
Wang L; Park JY; Liu F; Olesen KM; Hou S; Peng JC; Infield J; Levesque AC; Wang YD; Jin H; Fan Y; Connelly PJ; Pruett-Miller SM; Hu MG; Hinds PW; Han YG
Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2206147119. PubMed ID: 36095192
[TBL] [Abstract][Full Text] [Related]
11. CDK4: a master regulator of the cell cycle and its role in cancer.
Baker SJ; Poulikakos PI; Irie HY; Parekh S; Reddy EP
Genes Cancer; 2022; 13():21-45. PubMed ID: 36051751
[TBL] [Abstract][Full Text] [Related]
12. Realization of the T Lineage Program Involves GATA-3 Induction of Bcl11b and Repression of Cdkn2b Expression.
Thompson PK; Chen ELY; de Pooter RF; Frelin C; Vogel WK; Lee CR; Venables T; Shah DK; Iscove NN; Leid M; Anderson MK; Zúñiga-Pflücker JC
J Immunol; 2022 Jul; 209(1):77-92. PubMed ID: 35705252
[TBL] [Abstract][Full Text] [Related]
13. Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells.
Harris R; Yang M; Schmidt C; Royet C; Singh S; Natarajan A; Morris M; Frezza C; Laman H
J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35670764
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.
Ng YLD; Ramberger E; Bohl SR; Dolnik A; Steinebach C; Conrad T; Müller S; Popp O; Kull M; Haji M; Gütschow M; Döhner H; Walther W; Keller U; Bullinger L; Mertins P; Krönke J
Nat Commun; 2022 Feb; 13(1):1009. PubMed ID: 35197447
[TBL] [Abstract][Full Text] [Related]
15. CDK6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.
Zhang X; Sun Y; Cheng S; Yao Y; Hua X; Shi Y; Jin X; Pan J; Hu MG; Ying P; Hou X; Xia D
Cell Cycle; 2022 May; 21(9):984-1002. PubMed ID: 35167417
[TBL] [Abstract][Full Text] [Related]
16. Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.
Dalecki AG; Greer BD; Duverger A; Strange EL; Carlin E; Wagner F; Shi B; Lowman KE; Perez M; Tidwell C; Kaczmarek Michaels K; Giattina S; Bossmann SH; Henderson AJ; Hu H; Kutsch O
J Virol; 2022 Mar; 96(5):e0197421. PubMed ID: 35019721
[TBL] [Abstract][Full Text] [Related]
17. Genetic landscape of T cells identifies synthetic lethality for T-ALL.
O'Meara CP; Guerri L; Lawir DF; Mateos F; Iconomou M; Iwanami N; Soza-Ried C; Sikora K; Siamishi I; Giorgetti O; Peter S; Schorpp M; Boehm T
Commun Biol; 2021 Oct; 4(1):1201. PubMed ID: 34671088
[TBL] [Abstract][Full Text] [Related]
18. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia.
Gao X; Qin S; Wu Y; Chu C; Jiang B; Johnson RH; Kuang D; Zhang J; Wang X; Mehta A; Tew KD; Leone GW; Yu XZ; Wang H
J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34255748
[TBL] [Abstract][Full Text] [Related]
19. T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses
Klein K; Witalisz-Siepracka A; Gotthardt D; Agerer B; Locker F; Grausenburger R; Knab VM; Bergthaler A; Sexl V
Front Immunol; 2021; 12():650977. PubMed ID: 34248938
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
